1. Home
  2. EXFY vs MBX Comparison

EXFY vs MBX Comparison

Compare EXFY & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXFY
  • MBX
  • Stock Information
  • Founded
  • EXFY 2008
  • MBX 2018
  • Country
  • EXFY United States
  • MBX United States
  • Employees
  • EXFY N/A
  • MBX N/A
  • Industry
  • EXFY Computer Software: Prepackaged Software
  • MBX
  • Sector
  • EXFY Technology
  • MBX
  • Exchange
  • EXFY Nasdaq
  • MBX NYSE
  • Market Cap
  • EXFY 309.9M
  • MBX 347.9M
  • IPO Year
  • EXFY 2021
  • MBX 2024
  • Fundamental
  • Price
  • EXFY $2.78
  • MBX $7.62
  • Analyst Decision
  • EXFY Buy
  • MBX Strong Buy
  • Analyst Count
  • EXFY 4
  • MBX 5
  • Target Price
  • EXFY $5.00
  • MBX $37.40
  • AVG Volume (30 Days)
  • EXFY 338.3K
  • MBX 339.5K
  • Earning Date
  • EXFY 05-08-2025
  • MBX 05-16-2025
  • Dividend Yield
  • EXFY N/A
  • MBX N/A
  • EPS Growth
  • EXFY N/A
  • MBX N/A
  • EPS
  • EXFY N/A
  • MBX N/A
  • Revenue
  • EXFY $139,236,000.00
  • MBX N/A
  • Revenue This Year
  • EXFY $9.56
  • MBX N/A
  • Revenue Next Year
  • EXFY $6.86
  • MBX N/A
  • P/E Ratio
  • EXFY N/A
  • MBX N/A
  • Revenue Growth
  • EXFY N/A
  • MBX N/A
  • 52 Week Low
  • EXFY $1.24
  • MBX $4.81
  • 52 Week High
  • EXFY $4.13
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • EXFY 42.68
  • MBX N/A
  • Support Level
  • EXFY $2.65
  • MBX N/A
  • Resistance Level
  • EXFY $2.87
  • MBX N/A
  • Average True Range (ATR)
  • EXFY 0.21
  • MBX 0.00
  • MACD
  • EXFY 0.01
  • MBX 0.00
  • Stochastic Oscillator
  • EXFY 47.62
  • MBX 0.00

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: